Indication
Nulojix, in combination with corticosteroids and a mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- NulojixBrazil · Bristol-Myers Squibb Farmacêutica LtdaSame brand
- Nulojix 250 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 275 mg · polvo para concentrado para solución para perfusión · Bristol-Myers Squibb Pharma EeigSame brand
- NulojixCroatiaSame brand
- Nulojix 25 mg/ml, poeder voor concentraat voor oplossing voor infusie